We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

146 hedge funds and large institutions have $345M invested in Surmodics in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

12% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 43

8% more funds holding

Funds holding: 135146 (+11)

5% less capital invested

Capital invested by funds: $362M → $345M (-$16.9M)

4.45% less ownership

Funds ownership: 85.21%80.75% (-4.5%)

14% less call options, than puts

Call options by funds: $5.24M | Put options by funds: $6.12M

Holders
146
Holders Change
+11
Holders Change %
+8.15%
% of All Funds
1.91%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
48
Reduced
43
Closed
17
Calls
$5.24M
Puts
$6.12M
Net Calls
-$877K
Net Calls Change
+$2.96M

SRDX Hedge Fund Activity: Q3 2025 in Review

146 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2025, worth a combined $345M — down 4.7% from $362M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SRDX positions and 17 closed out — a net gain of 11 holders — while 48 added to existing stakes and 43 trimmed.

The largest buyer was ODDO BHF Asset Management, adding an estimated $11.4M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $23.4M sold.

  • 146 institutional investors held Surmodics (SRDX) as of Q3 2025, up from 135 in Q2 2025.
  • Funds reported $345M of Surmodics stock for Q3 2025, down 4.7% quarter-over-quarter.
  • 28 funds opened new Surmodics positions in Q3 2025 and 17 closed out, a net change of +11 holders.
  • The largest Surmodics buyer in Q3 2025 was ODDO BHF Asset Management, an estimated $11.4M added.
  • The largest Surmodics seller in Q3 2025 was Soleus Capital Management, an estimated $23.4M sold.

Based on aggregated 13F filings for Q3 2025.